NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ·Healthcare·Biotechnology
$29.80
-1.23%
Mkt Cap $3.54B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (11 analysts)
$46.00
Range $37.00 – $55.00
Implied Upside
+54.4%
Consensus $46.00 vs current $29.80
NASDAQ·Healthcare·Biotechnology
$29.80
-1.23%
Mkt Cap $3.54B
Buy
3
Hold
0
Sell
0
Price Target (11 analysts)
$46.00
Range $37.00 – $55.00
+54.4%
Consensus $46.00 vs current $29.80